Seikagaku Corporation
4548
Rank in Stocks
#16936
Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947,... Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947, specializes in the global development, manufacturing, and distribution of pharmaceuticals and medical devices, with a core focus on glycoconjugates. The company, which was formerly known as K.K. Seikagaku Kenkyusho until its name change in 1962, operates through two primary segments: Pharmaceuticals and LAL. Its product portfolio encompasses a range of therapeutic and surgical solutions. For joint health, Seikagaku provides intra-articular injections like ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX, designed to enhance joint function. The company also supplies ophthalmic surgical aids such as OPEGAN, OPEGAN Hi, and SHELLGAN, alongside MucoUp for endoscopic mucosal resection. Other notable offerings include Gel-One, a cross-linked hyaluronate hydrogel addressing knee osteoarthritis, and HERNICORE for lumbar disc herniation. Beyond finished products, Seikagaku is a supplier of bulk materials, specifically sodium hyaluronate and sodium chondroitin sulfate, which find application in various pharmaceutical and cosmetic formulations. Furthermore, the company develops and markets specialized endotoxin-detecting reagents, including Pyrochrome, ENDOSPECY, and TOXICOLOR, which are crucial for quality assurance in injectable pharmaceuticals, biological products, medical devices, manufacturing operations, and dialysate water quality. Its offerings also extend to oral care, featuring the KINUSUI Spray mouthwash. Seikagaku maintains a robust development pipeline, with promising candidates such as SI-6603 for lumbar disc herniation, SI-614 (a modified hyaluronate for dry eyes), SI-613 for osteoarthritis, SI-613-ETP targeting enthesopathy, and SI-449, a powdered adhesion barrier.
Share Price
$3.44
Last synced: 2026-11-10
Market Cap
$188.02M
Change (1 day)
1.68%
Change (1 year)
-20.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Seikagaku Corporation (4548)
Category
Healthcare
Operating Margin for Seikagaku Corporation (4548)
Operating Margin as of November 2026 TTM: -3.37%
According to Seikagaku Corporation's latest financial reports, its current operating margin (TTM) is -3.37%. At the end of 2025 the company had an operating margin of 3.39%.
Operating Margin history for Seikagaku Corporation from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3.37% | -199.41% |
| 2025 | 3.39% | 182.50% |
| 2024 | 1.20% | -81.01% |
| 2023 | 6.32% | -51.01% |
| 2022 | 12.90% | 58.67% |
| 2021 | 8.13% | 18.86% |
| 2020 | 6.84% | 98.84% |
| 2019 | 3.44% | -26.96% |
| 2018 | 4.71% | 8.78% |
| 2017 | 4.33% | -37.43% |
| 2016 | 6.92% | -14.25% |
| 2015 | 8.07% | -51.59% |
| 2014 | 16.67% | 42.11% |
| 2013 | 11.73% | -31.20% |
| 2012 | 17.05% | 30.85% |
| 2011 | 13.03% | -29.57% |
| 2010 | 18.50% | 6.44% |
| 2009 | 17.38% | -28.06% |
| 2008 | 24.16% | 5.59% |
| 2007 | 22.88% | -23.27% |
| 2006 | 29.82% | -0.83% |
| 2005 | 30.07% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -104.52% |
US
|
|
| 18.08% | -105.36% |
IE
|
|
| 21.25% | -106.31% |
US
|
|
| 21.05% | -106.25% |
US
|
|
| 28.09% | -108.34% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Seikagaku Corporation's operating margin
What is Seikagaku Corporation's operating margin?
Seikagaku Corporation's operating margin is -3.37%, as of Nov 2026.
What was Seikagaku Corporation's operating margin in 2025?
In 2025, Seikagaku Corporation's operating margin was 3.39%, compared with 1.20% in 2024.
How has Seikagaku Corporation's operating margin changed since 2020?
From 2020 to 2025, Seikagaku Corporation's operating margin was highest in 2022 (12.90%) and lowest in 2024 (1.20%).
How does Seikagaku Corporation's operating margin compare with similar companies?
Seikagaku Corporation's operating margin (-3.37%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.